ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
22.785,52
-0,94%
S&P 500
5.770,20
0,55%
Dow Jones
42.801,72
0,00%
Euro vs US Dollar
1,08539
0,20%
Bitcoin
83.352,23
3,43%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. LAVA Therapeutics NV (LVTX) Börsenkurse

LAVA Therapeutics NV

LAVA Therapeutics NV (LVTX)

NASDAQ
1,44
0,03
(2,13%)
Geschlossen 08 März 10:00PM
Verzögert um 15 Minuten
1,44
0,00
( 0,00% )
Vor Marktöffnung: 12:16PM
Verzögert um 15 Minuten
Fortg. Diagramm

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
1,44
Gebot
1,40
Fragen
1,44
Volumen
20
0,00 Tagesbereich 0,00
0,8502 52-Wochen-Bereich 4,21
Marktkapitalisierung
37,856M
Handelsende
1,44
Handelsbeginn
-
Letzte Trade
5
@
1.44
Letzter Handelszeitpunkt
11:38:09
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
499.126
Ausgegebene Aktien
26.289.087
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,90
Gewinn pro Aktie (EPS)
-1,6
Erlöse
6,77M
Nettogewinn
-41,97M

Über LAVA Therapeutics NV

LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells. LAVA Therapeutics NV is a biotechnology company. It is focused on transforming cancer treatment by developing a platform of novel bispecific antibodies designed to selectively induce gamma-delta T cell-mediated immunity against tumor cells.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.lavatherapeutics.com
Hauptsitz
Utrecht, Utrecht, Nld
Gegründet
-
LAVA Therapeutics NV is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker LVTX. The last closing price for LAVA Therapeutics NV was US$1,44. Over the last year, LAVA Therapeutics NV shares have traded in a share price range of US$ 0,8502 to US$ 4,21.

LAVA Therapeutics NV currently has 26.289.087 shares in issue. The market capitalisation of LAVA Therapeutics NV is US$37,86 million. LAVA Therapeutics NV has a price to earnings ratio (PE ratio) of -0.90.

LVTX Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report
Edgar (US Regulatory)
28 Februar 2025
LVTX (2,13%)

Form 8-K - Current report
Edgar (US Regulatory)
25 Februar 2025
LVTX (2,13%)

Form 8-K - Current report
Edgar (US Regulatory)
02 Januar 2025
LVTX (2,13%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
10 Dezember 2024
LVTX (2,13%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
20 August 2024
LVTX (2,13%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
06 Juni 2024
LVTX (2,13%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
21 Mai 2024
LVTX (2,13%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
16 November 2023
LVTX (2,13%)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Edgar (US Regulatory)
22 August 2023
LVTX (2,13%)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.139.923664122141.311.511.251636201.36012298CS
40.48500.961.510.850212337151.33511796CS
120.3633.33333333331.081.510.85024991261.29187187CS
26-0.31-17.71428571431.752.0930.85022597801.34361589CS
52-0.91-38.72340425532.354.210.85021953071.8342105CS
156-3.04-67.85714285714.487.380.85023427212.8735187CS
260-10.04-87.45644599311.4817.20.85022772233.26295505CS

LVTX - Frequently Asked Questions (FAQ)

What is the current LAVA Therapeutics NV share price?
The current share price of LAVA Therapeutics NV is US$ 1,44
How many LAVA Therapeutics NV shares are in issue?
LAVA Therapeutics NV has 26.289.087 shares in issue
What is the market cap of LAVA Therapeutics NV?
The market capitalisation of LAVA Therapeutics NV is USD 37,86M
What is the 1 year trading range for LAVA Therapeutics NV share price?
LAVA Therapeutics NV has traded in the range of US$ 0,8502 to US$ 4,21 during the past year
What is the PE ratio of LAVA Therapeutics NV?
The price to earnings ratio of LAVA Therapeutics NV is -0,9
What is the cash to sales ratio of LAVA Therapeutics NV?
The cash to sales ratio of LAVA Therapeutics NV is 5,59
What is the reporting currency for LAVA Therapeutics NV?
LAVA Therapeutics NV reports financial results in USD
What is the latest annual turnover for LAVA Therapeutics NV?
The latest annual turnover of LAVA Therapeutics NV is USD 6,77M
What is the latest annual profit for LAVA Therapeutics NV?
The latest annual profit of LAVA Therapeutics NV is USD -41,97M
What is the registered address of LAVA Therapeutics NV?
The registered address for LAVA Therapeutics NV is YALELAAN 62, UTRECHT, UTRECHT, 3584 CM
What is the LAVA Therapeutics NV website address?
The website address for LAVA Therapeutics NV is www.lavatherapeutics.com
Which industry sector does LAVA Therapeutics NV operate in?
LAVA Therapeutics NV operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
RDFNRedfin Corporation
US$ 10,2599
(76,29%)
12,27M
STSSSharps Technology Inc
US$ 0,4937
(66,40%)
89,39M
CKPTCheckpoint Therapeutics Inc
US$ 4,10
(65,99%)
3,12M
LGHLWLion Group Holding Ltd
US$ 0,01
(56,25%)
7
MLYSMineralys Therapeutics Inc
US$ 15,3623
(46,03%)
2,09M
LEGHLegacy Housing Corporation
US$ 16,48
(-34,16%)
7
SNESSenesTech Inc
US$ 2,01
(-33,22%)
10,92k
GEOSGeospace Technologies Corporation
US$ 5,33
(-28,65%)
17
ABLVAble View Global Inc
US$ 1,34
(-22,99%)
252,96k
XMTRXometry Inc
US$ 19,01
(-22,82%)
17
STSSSharps Technology Inc
US$ 0,4937
(66,40%)
89,39M
ICONIcon Energy Corporation
US$ 0,1913
(13,33%)
39,81M
BTOGBit Origin Ltd
US$ 0,5006
(-19,26%)
30,39M
RDFNRedfin Corporation
US$ 10,2599
(76,29%)
12,27M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 9,945
(-6,71%)
11,47M

LVTX Finanzen

Finanzen

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
LVTX
LAVA Therapeutics NV
LSE
TYMN
Tyman
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten

Werbung entfernen

Melden Sie sich für ein werbefreies Erlebnis an

Keine Werbung

Versuchen Sie es jetzt

Anzeigen behalten